BP-C1 in Metastatic Breast Cancer Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 19, 2014

Primary Completion Date

January 20, 2016

Study Completion Date

January 20, 2016

Conditions

Metastatic Breast CancerStage IV Breast Cancer

Interventions

DRUG

BP-C1

BP-C1, 0.05% solution for injection; doses: 0.035 mg/kg body weight (0.07 mL/kg) intramuscularly once daily for 32 consecutive days

Trial Locations (2)

Lampang Cancer Center, Lampang

Oncology Unit. Sheba Medical Centre, Ramat Gan